Expert consensus on the clinical diagnosis and treatment of ovarian cancer ascites with integrated traditional Chinese and Western medicine

LI He; ZHANG Xu; YING Liang; RU Dan; DING Chenghuan; YU Chaoqin; ZHANG Tingting; XU Lianwei; DONG Li

doi:10.16305/j.1007-1334.2024.04

您当前的位置：

首页 >

文章列表页 >

Expert consensus on the clinical diagnosis and treatment of ovarian cancer ascites with integrated traditional Chinese and Western medicine

更新时间：2024-07-04

- Expert consensus on the clinical diagnosis and treatment of ovarian cancer ascites with integrated traditional Chinese and Western medicine
- Shanghai Journal of Traditional Chinese Medicine Vol. 58, Issue 增刊1, Pages: 17-21(2024)
- 作者机构：
  
  1.上海交通大学医学院附属仁济医院（上海 200127）
  2.上海长海医院（上海 200433）
  3.上海中医药大学附属岳阳中西医结合医院（上海 200437）
  4.上海中医药大学附属龙华医院（上海 200032）
- 作者简介：
- 基金信息：
- DOI：10.16305/j.1007-1334.2024.04
  CLC：
- Published：10 June 2024，
  
  Received：19 April 2024，
- 稿件说明：
扫描看全文
李鹤,张旭,应亮,等.卵巢癌腹水中西医结合临床诊疗专家共识[J].上海中医药杂志,2024,58(增刊1):17-21.

LI He,ZHANG Xu,YING Liang,et al.Expert consensus on the clinical diagnosis and treatment of ovarian cancer ascites with integrated traditional Chinese and Western medicine[J].Shanghai Journal of Traditional Chinese Medicine,2024,58(增刊1):17-21.
李鹤,张旭,应亮,等.卵巢癌腹水中西医结合临床诊疗专家共识[J].上海中医药杂志,2024,58(增刊1):17-21. DOI： 10.16305/j.1007-1334.2024.04.

LI He,ZHANG Xu,YING Liang,et al.Expert consensus on the clinical diagnosis and treatment of ovarian cancer ascites with integrated traditional Chinese and Western medicine[J].Shanghai Journal of Traditional Chinese Medicine,2024,58(增刊1):17-21. DOI： 10.16305/j.1007-1334.2024.04.

摘要

Abstract

关键词

卵巢癌腹水海派中医妇科上海专家共识中西医结合

Keywords

ovarian cancer ascitesShanghai school of Chinese medicine gynecologyShanghai expert consensusintegration of traditional Chinese and Western medicine

references

YAN B B，XIONG C Q，HUANG F F，et al.Big data-based identification of methylated genes associated with drug resistance and prognosis in ovarian cancer［J］. Medicine（Baltimore）， 2020， 99（27）： e20802.

WHITESIDE T L.The tumor microenvironment and its role in promoting tumor growth［J］. Oncogene， 2008， 27（45）： 5904 -5912.

DI J，DUIVEMAN-DE BOER T，FIGDOR C G，et al. Aiming to immune elimination of ovarian cancer stem cells［J］. World J Stem Cells， 5（4）： 149-162.

CURTIS M，MUKHERJEE A， ENGYEL E.The tumor microenvironment takes center stage in ovarian cancer metastasis［J］. Trends Cancer， 2018， 4（8）： 517 -551.

BOWTELL D D，BÖHM S，AHMED A A，et al. Rethinking ovarian cancer Ⅱ：reducing mortality from high-grade serous ovarian cancer［J］. Nat Rev Cancer， 2015， 15（11）： 668-679.

CASCALES-CAMPOS P，LÓPEZ-LÓPEZ V，GIL J，et al. Hyperthermic intraperitoneal chemotherapy with paclitaxel or cisplatin in patients with stage Ⅲ-C/Ⅳ ovarian cancer. Is there any difference？［J］. Surg Oncol， 2016， 25（3）： 164-170.

PAPANIKOLAOU S， BRAVOU V， PAPADAKI H， et al. The role of the endothelin axis in promoting epithelial to mesenchymal transition and lymph node metastasis in prostate adenocarcinoma［J］. Urol Ann，2017 ，9（4）： 372-379.

LAAKKONEN J P， LAPPALAINEN J P， THEELEN T L，et al. Differential regulation of angiogenic cellular processes and claudin-5 by histamine and VEGF via PI3K-signaling，transcription factor SNAI2 and interleukin-8［J］. Angiogenesis， 2017， 20（1）： 109-124.

WU X W， LIU L W， HE Y C， et al.The value of multi -tumor markers protein chip diagnosis system in the differential diagnosis of benign and malignant pleural effusion［J］. Anhui Med and Pharmaceutical J，2009， 13（3）： 286 -288.

GUO X X， DUAN M L， DU X G， et al.Clinical application of protein chip technology for detecting serum markers ［J］. Chin J Clin Lab Sci，2004， 22（3）： 224.

SÖLÉTORMOS G， DUFFY M J， OTHMAN ABU HASSAN S，et al.Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer：Updated Guidelines From the European Group on Tumor Markers［J］. Int J Gynecol Cancer， 2016， 26（1）： 43-51.

卢淮武，吴斌，许妙纯，等.《2022 NCCN卵巢癌包括输卵管癌及原发性腹膜癌临床实践指南（第1版）》解读［J］. 中国实用妇科与产科杂志，2022， 38（3）： 310-318.

李斌，杨全军，郭澄.癌症恶病质的诊断及药物治疗进展［J］.中国肿瘤，2013， 22（12）： 1006-1010.

GADDUCCI A，GUERRIERI M E. PARP Inhibitors in Epithelial Ovarian Cancer：State of Art and Perspectives of Clinical Research［J］. Anticancer Res， 2016， 36（5）： 2055-2064.

BAMIAS A，KOUTSOUKOU V，TERPOS E，et al.Correlation of NK T‑like CD3+CD56+ cells and CD4+CD25+（hi）regulatory T cells with VEGF and TNF‑α in ascites from advanced ovarian cancer：Association with platinum resistance and prognosis in patients receiving first-line，platinum-based chemotherapy［J］. Gynecol Oncol，2008， 108（2）： 421-427.

QI W X，FU S，ZHANG Q，et al.Bevacizumab increases the risk of severe congestive heart failure in cancer patients：an up-to-date meta-analysis with a focus on different subgroups［J］. Clin Drug Investig，2014， 34（10）： 681-690.

BAMIAS A， GIBBS E， KHOON L C， et al. Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer： exploratory analyses of the AURELIA trial［J］. Ann Oncol， 2017， 28（8）： 1842-1848.

MARCHETTI C， DE FELICE F， PALAIA I， et al. Efficacy and toxicity of bevacizumab in recurrent ovarian disease：an update meta-analysis on phase Ⅲ trials［J］. Oncotarget， 2016， 7（11）： 13221-13227.

Views

下载量

CSCD

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Shanghai expert consensus on "whole period" diagnosis and reatment of ovarian cancer with integrated traditional Chinese and Western medicine

Expert consensus on clinical diagnosis and treatment of myelosuppression in ovarian cancer with integrated Chinese and Western medicine

Integrated diagnosis and treatment expert consensus for myasthenia gravis based on characteristics of Shanghai style traditional Chinese medicine

On the academic thoughts of traditional Chinese medicine and my academic style

Related Author

DONG Li

XU Lianwei

ZHANG Tingting

YU Chaoqin

DING Chenhuan

ZHANG Xu

RU Dan

LI He

Related Institution

Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

The First Affiliated Hospital of Naval Medical University （Changhai Hospital of Shanghai）

Yueyang Hospital of Integrated Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine

Shanghai TCM‑Integrated Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

⁰